Robert Lorne Hopfner, Director at Vaxcyte, Inc. (PCVX), sold 34,004 shares at $25.06 ($854K) on 2021-02-03, disclosed to the SEC on 2021-02-04.
Open-market sale of $854k PCVX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.13 | 14,234 | $358K | 41.9% |
| 2 | $25.13 | 14,234 | $358K | 41.9% |
| 3 | $25.06 | 2,768 | $69K | 8.1% |
| 4 | $25.06 | 2,768 | $69K | 8.1% |
| Total | $25.12 avg | 34,004 | $854K | 100% |
| Filing → |
| INZY | BUY | 2023-05-15 | $5.7M | — | Filing → |
| INZY | BUY | 2023-03-30 | $3.1M | — | Filing → |
| INZY | BUY | 2023-03-29 | $1.7M | — | Filing → |